Sickle cell disease and readmissions rates after lower extremity arthroplasty: a multistate analysis 2007-2014.

TitleSickle cell disease and readmissions rates after lower extremity arthroplasty: a multistate analysis 2007-2014.
Publication TypeJournal Article
Year of Publication2019
AuthorsChen Y, White RS, Tangel V, Noori SA, Gaber-Baylis LK, Mehta ND, Pryor KO
JournalJ Comp Eff Res
Volume8
Issue6
Pagination403-422
Date Published2019 Apr
ISSN2042-6313
Abstract

AIM: To compare readmission rates between patients with sickle cell disease (SCD) and non-sickle cell disease undergoing total hip and knee arthroplasty (THA and TKA).

METHODS: Identified adult patients who underwent THA or TKA from 2007 to 2014 in California, Florida, New York, Maryland and Kentucky using a multistate database. Outcomes were 30- and 90-day readmission rates, mortality, complications, length of stay and hospital charges. Logistic regression models were used for analysis.

RESULTS: Compared with non-sickle cell disease patients following TKA and THA, SCD patients had higher odds of 30- (odds ratio [OR]: 3.79) and 90-day readmissions (OR: 4.15), mortality (OR: 6.54), more complications, longer length of stay, and higher total charges.

CONCLUSION: Following TKA and THA, SCD is associated with higher readmissions and worse outcomes.

DOI10.2217/cer-2018-0098
Alternate JournalJ Comp Eff Res
PubMed ID30892071

Center for Perioperative Outcomes
NewYork-Presbyterian Hospital 
Weill Cornell Medical Center
428 East 72nd Street, Suite 800A
New York, NY 10021
Phone: (646) 962-2671
Fax: (646) 962-0435